A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-09-29Est. Completion: 2028-06
Enrollment target: 80 participants Locations- Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels, Brussels Capital, Belgium
- Centre Hospitalier Regional De La Citadelle, Liège, Liege, Belgium
- Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur, Namur, Belgium
- Klinicki Bolnicki Centar Osijek, Osijek, Croatia, Croatia
- Children's Hospital Zagreb, Zagreb, Croatia, Croatia
- University Hospital Centre Zagreb, Zagreb, Croatia, Croatia
- Hospital Femme Mere Enfant, Bron, France, France
- Centre Hospitalier Universitaire De Dijon, Dijon, France, France
- Hopital Saint Vincent de Paul - GHICL Lille, Lille, France, France
- CHU de Montpellier, Montpellier, France, France
- Centre Hospitalier Universitaire De Rennes, Rennes, France, France
- Centre Hospitalier Regional Universitaire De Tours, Tours, France, France
- Universitaetsklinikum Aachen AöR, Aachen, Germany, Germany
- Universitaetsklinikum Leipzig AöR, Leipzig, Germany, Germany
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz, Germany, Germany
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Universitaetsklinikum Tuebingen AöR, Tübingen, Germany, GermanyAthens General Children's Hospital Panagioti And Aglaia Kyriakou, Athens, Greece, GreeceUniversity General Hospital Attikon, Athens, Greece, GreeceGeneral Hospital Of Thessaloniki Papageorgiou, Efkarpia, Greece, GreeceHippokration Hospital, Thessaloniki, Greece, GreeceChildren's Health Ireland, Dublin, Ireland, IrelandAzienda Ospedaliero-Universitaria Ss Antonio E Biagio E Cesare Arrigo, Alessandria, Italy, ItalyAzienda Ospedaliero Universitaria dell Marche I G M Lancisi G Salesi, Ancona, Italy, ItalyASST Fatebenefratelli Sacco, Milan, Italy, ItalyAzienda Ospedaliera Universitaria Federico II Di Napoli, Naples, Italy, ItalyAzienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy, ItalyOspedale Pediatrico Bambino Gesu, Rome, Italy, ItalyIRCCS Materno Infantile Burlo Garofolo, Trieste, Italy, ItalyOslo University Hospital HF, Oslo, Norway, NorwaySykehuset I Vestfold HF, Tønsberg, Norway, NorwayIn Vivo Sp. z o.o., Bydgoszcz, Poland, PolandInstytut Centrum Zdrowia Matki Polki, Lodz, Poland, PolandGabinet Lekarski Bartosz Korczowski, Rzeszów, Poland, PolandInstytut Pomnik Centrum Zdrowia Dziecka, Warsaw, Poland, PolandCCAB Centro Clinico Academico Braga Associacao, Braga, Portugal, PortugalHospital Pediátrico de Coimbra, Coimbra, Portugal, PortugalUnidade Local De Saude Do Alto Minho E.P.E., Viana do Castelo, Portugal, PortugalDr. Victor Gomoiu Clinical Children Hospital, Bucharest, Romania, RomaniaSpitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara, Timișoara, Romania, RomaniaHospital Germans Trias I Pujol, Badalona, Spain, SpainHospital Universitario Reina Sofia, Córdoba, Spain, SpainBristol Royal Infirmary, Bristol, United KingdomNinewells Hospital, Glasgow, United KingdomAlder Hey Children's Hospital, Liverpool, United KingdomChelsea and Westminster Hospital, London, United KingdomSheffield Children's Hospital, Sheffield, United KingdomRecruiting
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029